Nobilis Health Corp. (HLTH)
(Delayed Data from AMEX)
$0.22 USD
0.00 (-0.90%)
Updated May 3, 2019 04:13 PM ET
After-Market: $0.22 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.22 USD
0.00 (-0.90%)
Updated May 3, 2019 04:13 PM ET
After-Market: $0.22 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
AMN Healthcare Services (AMN) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 4.30% and 0.73%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Cue Health Inc. (HLTH) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 28.89% and 6.81%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of -21.88% and 31.46%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Augmedix, Inc. (AUGX) Soars 7.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Augmedix, Inc. (AUGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Cue Health Inc. (HLTH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 3.77% and 10.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Cue Health Inc. (HLTH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
Cue Health Inc. (HLTH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Cue Health Inc. (HLTH) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Cue Health Inc. (HLTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cue Health Inc. (HLTH) Loses -47.82% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Cue Health Inc. (HLTH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Cue Health Inc. (HLTH) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 21.82% and 19.92%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Hims & Hers Health, Inc. (HIMS) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of 18.18% and 11.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cue Health Inc. (HLTH) Upgraded to Buy: Here's Why
by Zacks Equity Research
Cue Health Inc. (HLTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why Cue Health (HLTH) Might Surprise This Earnings Season
by Zacks Equity Research
Cue Health (HLTH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is Nobilis Health (HLTH) a Great Stock for Value Investors Right Now?
by Zacks Equity Research
Nobilis Health (HLTH) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Health Insurance Stock Outlook - January 2018
by Zacks Equity Research
Rapid evolution is being witnessed in the health insurance industry as the players are taking concerted efforts to transform themselves into comprehensive health care providers from their earlier role of traditional payers.
5 HMO Stocks to Continue Rewarding Investors
by Sejuti Banerjea
Here are five Buy-rated HMO stocks that should be in your portfolio.
Top Ranked Value Stocks to Buy for July 17th
by Zacks Equity Research
Here are three stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, July 17th:
Top Ranked Growth Stocks to Buy for July 17th
by Zacks Equity Research
Here are three stocks with Zacks Rank #1 (Strong Buy) and strong growth characteristics for investors to consider today, July 17th:
Top Ranked Value Stocks to Buy for July 12th
by Zacks Equity Research
Here are three stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, July 12th:
Top Ranked Growth Stocks to Buy for July 12th
by Zacks Equity Research
Here are three stocks with Zacks Rank #1 (Strong Buy) and strong growth characteristics for investors to consider today, July 12th:
The Zacks Analyst Blog Highlights: Nobilis Health, Extended Stay America, SYNNEX, Citizens Financial Group and W&T Offshore
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nobilis Health, Extended Stay America, SYNNEX, Citizens Financial Group and W&T Offshore
Top Ranked Growth Stocks to Buy for July 11th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 11th:
Advisory Board (ABCO) in Focus: Stock Moves 5.4% Higher
by Zacks Equity Research
Advisory Board (ABCO) was a big mover last session, as the company saw its shares rise over 5% on the day.
US Job Market Roars Back to Life: Top 5 Gainers
by Tirthankar Chakraborty
The U.S. economy created 222,000 new jobs in June, the second largest addition in the year, while hiring was also stronger in May and April than previously reported.
Top Ranked Value Stocks to Buy for July 10th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, July 10th:
Top Ranked Growth Stocks to Buy for July 6th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong growth characteristics for investors to consider today, July 6th: